In Vitro Expansion of Fetal Liver Hematopoietic Stem Cells

Overview

Journal Sci Rep

Specialty Science

Date 2021 Jun 5

PMID 34088934

Citations 6

Authors

Rashmi Bhardwaj

Lalit Kumar

Deepika Chhabra

N K Mehra

Atul Sharma

Sujata Mohanty

Vinod Kochupillai

Affiliations

Soon will be listed here.

Abstract

Fetal liver hematopoietic stem and progenitor cells (HSPCs) have been considered appropriate for the management of aplastic anemia owing to their proliferative potential. Bone marrow recovery was possible in some cases; the engraftment potential of these cells, however was unsatisfactory, possibly due to the availability of a smaller number of these cells from a single fetus. The present study explores how we can expand fetal liver hematopoietic stem cells under in vitro conditions. We isolated mononuclear cells from fetal liver and hematopoietic stem cells were identified and analyzed by cell surface marker CD34. CD34 fetal liver HSPCs cells were separated by magnetic cell sorting positive selection method. HSPCs (CD34) were cultured by using 5 cytokines, stem cell factor (SCF), granulocyte macrophages-colony stimulating factor (GM-CSF), interleukin-6 (IL-6), Fms-related tyrosine kinase 3 (FLT-3) and erythropoietin (EPO), in 4 different combinations along with supplements, in serum-free culture media for 21 days. Cell viability continued to be greater than 90% throughout 21 days of culture. The cells expanded best in a combination of media, supplements and 5 cytokines, namely SCF, FLT-3, IL6, EPO and GM-CSF to yield a large number of total (CD34 & CD34) cells. Even though the total number of nucleated cells increased in culture significantly, levels of CD34 antigen expression declined steadily over this period.

Citing Articles

Transduction of Human Fetal Liver Hematopoietic CD34+ Stem and Progenitor Cells into a Cell Line by Enhancing Telomerase Activity.

Bhardwaj R, Kumar L, Chhabra D, Sharma A, Mohanty S, Mehra N Int J Hematol Oncol Stem Cell Res. 2024; 18(4):330-343.

PMID: 39703476 PMC: 11652691. DOI: 10.18502/ijhoscr.v18i4.16758.

Uricase-Expressing Engineered Macrophages Alleviate Murine Hyperuricemia.

Feng Y, Cheng H, Xiong G, Cui J, Chen Z, Lu Y Biomedicines. 2024; 12(11).

PMID: 39595167 PMC: 11592275. DOI: 10.3390/biomedicines12112602.

Beyond Vision: An Overview of Regenerative Medicine and Its Current Applications in Ophthalmological Care.

Santa Cruz-Pavlovich F, Bolanos-Chang A, Del Rio-Murillo X, Aranda-Preciado G, Razura-Ruiz E, Santos A Cells. 2024; 13(2).

PMID: 38247870 PMC: 10814238. DOI: 10.3390/cells13020179.

Cell therapy in end-stage liver disease: replace and remodel.

Hu X, Chen L, Wu H, Tang Y, Zheng Q, Wei X Stem Cell Res Ther. 2023; 14(1):141.

PMID: 37231461 PMC: 10210428. DOI: 10.1186/s13287-023-03370-z.

Spatial transcriptomic profiling to identify mesoderm progenitors with precision genomic screening and functional confirmation.

Liu G, Yang G, Zhao G, Guo C, Zeng Y, Xue Y Cell Prolif. 2022; 55(10):e13298.

PMID: 35906841 PMC: 9528766. DOI: 10.1111/cpr.13298.

References

Mohamed A, Ibrahim A, El-Masry M, Mansour I, Khroshied M, Gouda H . Ex vivo expansion of stem cells: defining optimum conditions using various cytokines. Lab Hematol. 2006; 12(2):86-93. DOI: 10.1532/LH96.05033. View

Arjmand B, Goodarzi P, Aghayan H, Payab M, Rahim F, Alavi-Moghadam S . Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model. Front Endocrinol (Lausanne). 2019; 10:761. PMC: 6856665. DOI: 10.3389/fendo.2019.00761. View

McNiece I, Langley K, Zsebo K . Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol. 1991; 19(3):226-31. View

Mehra N, Taneja V, Jhinghon B, Chaudhuri T, Sharma S, Kochupillai V . HLA status following fetal liver transplantation in aplastic anaemia and acute myeloid leukaemia. Thymus. 1987; 10(1-2):131-6. DOI: 10.1007/978-94-009-3365-1_15. View

Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J . Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997; 89(8):2644-53. View

Rebel V, Miller C, Eaves C, Lansdorp P . The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their liver adult bone marrow counterparts. Blood. 1996; 87(8):3500-7. View

Su R, Zhang X, Li K, Yang M, Li C, Fok T . Platelet-derived growth factor promotes ex vivo expansion of CD34+ cells from human cord blood and enhances long-term culture-initiating cells, non-obese diabetic/severe combined immunodeficient repopulating cells and formation of adherent cells. Br J Haematol. 2002; 117(3):735-46. DOI: 10.1046/j.1365-2141.2002.03500.x. View

Kuchma M, Kyryk V, Svitina H, Shablii Y, Lukash L, Lobyntseva G . Comparative Analysis of the Hematopoietic Progenitor Cells from Placenta, Cord Blood, and Fetal Liver, Based on Their Immunophenotype. Biomed Res Int. 2015; 2015:418752. PMC: 4540977. DOI: 10.1155/2015/418752. View

Li J, Zhang L, Yin L, Ma N, Wang T, Wu Y . In Vitro Expansion of Hematopoietic Stem Cells by Inhibition of Both GSK3 and p38 Signaling. Stem Cells Dev. 2019; 28(22):1486-1497. PMC: 9208333. DOI: 10.1089/scd.2019.0119. View

10.

Fox N, Priestley G, Papayannopoulou T, Kaushansky K . Thrombopoietin expands hematopoietic stem cells after transplantation. J Clin Invest. 2002; 110(3):389-94. PMC: 151089. DOI: 10.1172/JCI15430. View

11.

Lacaud G, Kouskoff V . Hemangioblast, hemogenic endothelium, and primitive versus definitive hematopoiesis. Exp Hematol. 2017; 49:19-24. DOI: 10.1016/j.exphem.2016.12.009. View

12.

Nicolini F, Cashman J, Hogge D, Humphries R, Eaves C . NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia. 2003; 18(2):341-7. DOI: 10.1038/sj.leu.2403222. View

13.

Barcena A, Muench M, Kapidzic M, Fisher S . A new role for the human placenta as a hematopoietic site throughout gestation. Reprod Sci. 2009; 16(2):178-87. PMC: 2731631. DOI: 10.1177/1933719108327621. View

14.

Fietz T, Berdel W, Rieder H, Reufi B, Hopp H, Thiel E . Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cells. Bone Marrow Transplant. 1999; 23(11):1109-15. DOI: 10.1038/sj.bmt.1701776. View

15.

Lazzari L, Lucchi S, Rebulla P, Porretti L, Puglisi G, Lecchi L . Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system. Br J Haematol. 2001; 112(2):397-404. DOI: 10.1046/j.1365-2141.2001.02528.x. View

16.

Kochupillai V, Sharma S, Francis S, Nanu A, Mathew S, Bhatia P . Fetal liver infusion in aplastic anaemia. Thymus. 1987; 10(1-2):95-102. DOI: 10.1007/978-94-009-3365-1_10. View

17.

Matsunaga T, Kato T, Miyazaki H, Ogawa M . Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: comparison with the effects of FLT3/FLK-2 ligand and interleukin-6. Blood. 1998; 92(2):452-61. View

18.

Chivu M, Diaconu C, Bleotu C, Alexiu I, Brasoveanu L, Cernescu C . The comparison of different protocols for expansion of umbilical-cord blood hematopoietic stem cells. J Cell Mol Med. 2004; 8(2):223-31. PMC: 6740219. DOI: 10.1111/j.1582-4934.2004.tb00277.x. View

19.

Kawada H, Ando K, Tsuji T, Shimakura Y, Nakamura Y, Chargui J . Rapid ex vivo expansion of human umbilical cord hematopoietic progenitors using a novel culture system. Exp Hematol. 1999; 27(5):904-15. DOI: 10.1016/s0301-472x(99)00012-0. View

20.

Schuster J, Stupnikov M, Ma G, Liao W, Lai R, Ma Y . Expansion of hematopoietic stem cells for transplantation: current perspectives. Exp Hematol Oncol. 2012; 1(1):12. PMC: 3514093. DOI: 10.1186/2162-3619-1-12. View